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Summa.ry 
Measurement of rates of propulsion in the small intestine 
in control and experimental groups of male Sprague-Dawley 
rats (200-250 g) were carried out as a means of assessing 
antidiarrhoeal activity of aqueous extracts of the leaf of 
Psidium guajava (Linn.), using morphine as the standard drug 
of reference. Hyperpropulsion (diarrhoea) was induced by 
gavaging rats in_a control group with Microlax, using ~henol 
red mixed .into it as a marker in the intestine,. and the mean 
rate of the hyperpropulsion wa~ determined. The normal rate 
of propulsioh, defined as the per centage of the length of 
the ileum traversed by the front of the dye in 1 h after 
gavaging animals·with a liquid paraffin-phenol red meal, was 
also determined in another control group. In experimental 
groups pretreated with enteral administration of either 
•. 
* Microlax is a registered trade name of a microenema 
produced by Pharmacia AB, S-751 82 Uppsala, Sweden. 
2 
morphine or aqueous extracts, 1 h before the challenge with 
Microlax, the per centage inhibition to the hyperpropulsive 
rate (antidiarrhoeal activity) was calculated. Both 
morphine and the extracts produced a dos~:-response relation-
ship in their antidiarrhoeal effects. A dose of 0.2 ml/kg 
fresh-leaf extract produced 95% inhibition of p~opulsion. 
This dose :is equiactive with·0.2 mgjkg of morphine ~ulphate. 
The antidiarrhoeal action of the extract may be due, in 
part, to the inhibition of the increased watery secretions 
that occur commonly in all acute diarrhoeal diseases and 
cholera. 
Introduction 
The drinking of poti~ns of decoctions of the leaf or of the 
leaf and root bark/stem of the guava plant, Psidium guajava 
Linn. (Myrtaceae), as well as chewing of the fresh leaf, 
have been employed in the treatment of acute diarrhoeal 
diseases·for many centuries in .folk medicine, especially in 
. . 
tropical areas of the globe where the plant grows naturally. 
In a prev~ous report by_this author, the antidiarrhoeal 
action of an alcoholic extract of the leaf was shown to be 
due, in ~art~ to the presence of a flavonoid compound 
identified as quercetin·. · Both the extract 
and the isolated compound elicited a concentration-response 
relationship in the inhibition of gastrointestinal release 
of acetylcholine in the electrically_ stimulated guinea-pig 
isolated ileum preparation,as well as a spasmolytic effect 
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on the spontaneously contracting isolated ileum, by acting 
directly on the smooth muscle fibres (Lutterodt, 1988). 
More than twenty identified compounds from the guava leaf 
have been reported in the literature (Seshadri and Vasishta, 
1965; Osman et al., 1974; Lutterodt, 1988). The medicinal 
' . 
uses of thE~ leaf as an analgesic, antidiarr~oeal (including 
cholera and related diarrhoes), and as a neuroleptic have 
also been reported (Singh, 1986; Lutterodt and Maleque, 
1988). Antibiotic and anti-inflammatory effects have been 
repor~ed by Watt and Breyer-Brandwijk (1962) and Middleton 
et al. (1981), respectively~ 
In diarrhoea, the abnormally frequent expulsj_on· of faeces 
of low constitency is due to disturbafi~e in the transport 
of water and electrolytes in the intestines. Despite the 
multiplicity of aetiologies, four major mechanisms responsi-
ble for the pathophysiology in water and electrolyte 
transport are i) increased luminal osmolarity, (osmotic 
diarrhoea), ii) increased elec~rolyte secretion (secretory 
diarrhoea), iii) decreased electrolyte absorption, and 
iv) deranged·intestinal motility, causing decreased transit 
t·ime ( Jinich, H. and Hersh, T., 1982). ThE~ actions of 
morphine, the prototypical antidiarrhoeal drug, on the 
gastrointestinal tract are mediated ·both centrally and 
locally (Galligan and Burks, 1983, Megen~, 1990), the most 
~mportant comp9nent being the stimulation of tfie net 
absorption of water and electrolytes in the small and large 
intestine in several sp~cies of animals, including man 
4 
(Awouters et al., 1983; Coupar, 1987). It is now widely 
accepted that, even though disorders in intestinal motility 
constitute part of the pathophysioiogical basis of 
diarrhoea, abnorma~ities in the intestinal transport of 
electrolytes and water play an important role in the genesis 
. . 
and maintenance of diarrhoea (Dobbins and Binder, 1981). 
I 
Indeed, it is now recognise~ that normalization of the 
deranged water and electrolyte transport across the mucosal 
cells ts a more useful therapeutic effect than any action on 
intestinal motility and propulsibn. 
The objective of this work was, therefore, tp verify whether 
the increased amount of intestinal watery secretions and 
loss of electrolytes as occurs in diarrhoea are diminished 
by the antidiarrhoeal principle(s) present in the ~eaf of 
Psidium guajava, as this effect, if shown to occur, would be 
a third possible mode of action. 
The choice of Microlax for the induction of experimental 
diarrhoea was based on the fact that its action is 
physiological and it does not stimulate the gut wall nor 
does it produce any systemic reactions. The main 
ingredients of Microlax are sorbitol, sodium citrate and 
sodium lauryl sulphoacetate. Sorbitol is a polyhdrolate 
compound and, like glycerol or lactulose, its emollient 
action producing mild catharsis is due to the osmotic 
effects that draw large amounts of water from the extra-
cellular space of intestinal tissues into the lumen. Sodium 
citrate similarly draws water into the lumen, reinforcing 
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the action of sorbitol, whereas sodium lauryl acetate, a 
non-toxic, non-irritant wetting agent, facilitates the 
penetration of the sodium citrate into faecal matter and 
thus enhances the cathartic effect. 
~ 
Although the annual global figures for mortality and 
I • 
morbidity due to diarrhoeal diseases in infants and young 
children, especially in developing countries,· remain very 
high,w!th an estimated 1,000 million episodes·of illness and 
some 4.5 million deaths in children under 5, excluding China 
(~ynder and Merson, 1982; Baltazar, J. et al., 1988), 
there appears to be a diminution in the knowledge of the use 
of traditional remedies for treating diarrhoeal diseases. 
A survey by questionnaire carried out in villages around the 
Kota Bahru area of Kelantan State, East Malaysia, showed 
that acute diarrhoeal disease is one of the major cause of 
morbidity in infants and young children of below 6 years. 
The unpublished report also showed that, even though the 
guava plant grows.wildly and abundantly in all these 
villages, 46.8% of householders interviewed were unaware of 
the antidiarrhoeal activity of the leaf of the plant (size 
of population in survey= 205). However, 91.9% of those 
with this knowledge of the use of ~he leaf testified to the 
9romptness and the efficacy of the antidiarrhoeal effect 
(Lutterodt, 1991, unpublished report). 
Megens, A.H.P. et al. (1990) studied gastrointestinal 
propulsion and the presence of diarrhoea in rats pretreated 
with various opioids and challenged orally with either 
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castor or paraffin oil, both of which contained phenol red 
as a marker of gastrointestinal propulsion. The method 
employed in the present study is a modification of that of 
Megens and co-workers. 
Although polar fractions of extracts of the leaf show 
I • 
narcotic-like effects in rats and mice (Lutterodt and 
Maleque, 1988 ;_ Lutterodt, 1988), its effects,' especially the 
inhibi~ion of acetylcholine release in the electrically 
driven guinea-pig isolated ileum, are not reversed by 
naloxone· .. · In experiments using -the--po-lar extract to produce 
a mouse narcotic-dependent model, there were no withdrawal 
symptoms (repeat~d vertical jumps, head-shakes, rearing, 
etc.) as occurs with opioids. Also when the aqueous 
extract, in various concentrations, was made the only source 
of watering in cages holding these narcotic-dependent model 
mice, there was only a slight initial increase in daily 
water consumption but this returned to normal levels, and 
stayed so, after about day-3 to day-5 of the 12 days period 
of observation (Lutterodt, 1991, unpublished report). 
Chemical analysis of the extract failed to show the presence 
of cannabinoid or opioid compounds ·(Lutterodt and Maleque, 
· 198~). Extracts of the leaf as used in the treatment of 




Male Sprague-Dawley rats ( 200-250 g.) obtained from the 
Animal Holding Unit, National University of Singapore, were 
housed in the Animal House or the School of Medical Sciences, 
Universiti Sains Malaysia, Kelantan subcampus~ at a 
controlled tempeiatur~ of 22 + 2°C. Experimental animals 
were fasted overnight (16 h) but ordinary water was made 
freely available as usual in the cages. 
Collection and drying of leaves 
The leaves were collected in the afternoon from kampungs 
(villages) surrounding the Kubang Kerian campus of the 
School of Medical Sciences, Universiti Sains Malaysia. 
After washing in tap water and air-drying in room 
temperature, the leaves were dried in a Memmert drier for 3 
days at 60°C. The dried leaves were then machine-ground 
into a coarse powder and stored at laboratory temperature 
(19 + 3°C). 
- . 
Preparation of extracts 
i) Aqueous extract of dried leaves: The powdered dry 
leaf (50 g) was soaked in 200 ml of water and heated 
to boiling which was then maintained for 1 h. After 
cooling to room temperature, the extract was seived 
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and then centrifuged for 15 min at 2000 rev.fmin. The 
supernatant was tested for possible antidiarrhoeal 
activity. 
ii) Aqueous extract of fresh leaves: The leaves were cut 
into very tiny pieces by hand and treated similarly to 
method (i) above. 
iii) Cold aqueous extract of fresh leaves: The leaves (50 g) 
. 
were cut into tiny pieces by hand and placed in 200 ml 
of cold water inside a Moulinette Chopper Blender 
(Model 647) and blended for 20 min at 20°C into a thin 
paste. The paste was pressed through a seive and the 
extract obtained was centrifuged for 15 min at 2000 
rev./min to obtain a clear straw-coloured solution. 
This was t~sted for antidiarrhoeal activity. 
Drugs, chemicals and doses 
i) Microlax is the trade name of a mild microenema 
produced by Pharmacia AB of Sweden. The composition/ml 
solution is 90 mg sodium citrate, 9 mg sodium lauryl-
sulphoacetate, 1 mg sobic acid, glycerol, sorbitol and 
purified water q.s. It was purchase~ from a local 
agent. 
The oral dose that induced diarrhoea in rats was 
approximately 8x the human microenema dose, equivalent 
to 1 ml/100 g body weight of a 1:9 (v/v) solution of 
Microlax in water. 
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ii) Morphine Sulphate Injection B.P. (10 mg/ml), from 
Makmal Ubat, Petaling Jaya, Malaysia, by courtesy of 
the Hospital Pharmacy Department, Universiti Sains 
Malaysia. The dose used was 0.4 ml/100 g body weight 
of 1:12.3 (v/v) of morphine injection in dist. H2o, 
equivalent to 0.3 mg/lqO g body weight . 
• iii) Phenol red was used as a dye marker of proximal phase 
of propulsion of both liquid paraffin (control animals) 
· and Micr.olax (test animals) by mixing it thoroughly 
into each liquid at 5 mg/ml concentration. 
iv) Liquid paraffin was obtained by courtesy of the 
Hospital Pharmacy Department, University Sains 
Malaysia Hospital, Kubang Kerian, Kelantan, Malaysia. 
The dose used was 1 ml/100 g body weight. 
Measurement of gastrointestinal rate of propulsion and 
antidiarrhoeal ~ctivity 
The rats (200-250 g) were caged ·and kept in a temperature-
regulated laboratory (19 ! 3°C) without food overnight (16 h) 
but they were supplied with freely ~vailable water as usua~ 
in the cages. On the morning of and 1 h before the 
experiment, control animals were gavaged with 1 ml water, 
whereas experimental animals received pretreatment with 
either morphine or a dose of aqueous extract! · 
One hour after this pretreatment, half the control rats 
were gavaged with the liquid p~raffin-dye meal and the other 
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half re6eived the Microlax-dye meal in similar fashion 
(Table 1). Three dose levels of morphine, 0.3, 1.0 and 2 mg/ 
100 g, were administered in three experimental groups (2a, · 
2b, 2c, respective.ly) 1 h before challenging with Microlax. 
Three types of aqueous extract, namely from dried powdered 
leaf (ED), fresh leaf (EF), ~nd freshly ground ~eaf paste 
extracted cold (EC), were administered in gro~ps 3a- 3d 
(Table 1). 
Measurement of gastrointestinal propulsion rate was limited 
to events in the small intestine, down to to the ileo--c·a:-ec-a-1-
junction, and was taken from the t·ime of gavaging the rat up 
to 60 minutes. At this cut-off time, the rat was sacrified 
immed~ately by cervical dislocation, followed by opening of 
the abdominal cavity and remo~al of the small intestine. 
The total length o~ the intestine (pyloric sphincter to 
ilea-caecal junction) and the length traversed by the dye 
were measured. It was necessary to mark the front of the 
dye with Indian ink immediately after exposure. 
In control animals gavaged with the paraffin oil-dye meal, 
the distance travelled by the meal in 60 min was taken as 
the normal rate of propulsion. 
Antisecretory, antipropulsive activity was expressed as the 
percentage of inhibition to propulsion of the dye front, 
taking into account the · · !ength of intestine 
with meal-dye to the total length of the isolated intestine· 
(Table 2). The mean hyperpropulsive rate (Grcup lb) in 
control animals (pretreate~ with solvent, H20) was taken as 
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the reference rate and the values obtained for protected 
animals (pretreated with morphine or extract 1 h before 
challenge with Microlax) were expressed as per centages of 
this value. The p~r cent inhibition was thus calculable 
for the various groups (Table 2). · 
Results 
The normal rate of propulsion in the small intestine in male 
Sprague-Dawley rats (200-250 g), using the liquid paraffin-
phenol red meaL was 75.4 + 6.0% h-1 . Microlax at a dose-of 
1.0 ml/100 g (commercial sample diluted 1:9 in water) 
produced 100% h-l propulsion in 61.1% of group lb animals 
% -1 and a mean value of 98.8! 1.8 h (n = 18), which was used 
as the reference value for hyperpropulsion. The mean t;ime 
for diarrhoea in whole rats was 95.1 min (n = 11). Table 2 
shows propulsion rates for the various experimental groups 
and the calculated inhibition per cent in each group, based 
on the value for control rats in group lb (Microlax gavage 
without previous protection with either morphine or extract). 
Fig. 1 shows the log dose-response for morphine on which are 
superimposed the inhibition activities of the various 
extracts for ease of reference to equiactivity to morphine. 
Comparing the extract prepare~ from oven-dried powdered 
leaves with that from fresh leaves, each of which was a 1:4. 
(wjv) extraction in boiling water for 1 h, the former showed 
greater activity of about 1.6 times the latter. The 
extraction in cold water, Ec, a 1:2 (w/v), showed a dose-
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response related activity, 2.0 ml/100 g of it producing an 
equiactive inhibition with 2 mg/kg morphine. From Table 2, 
1.0 ml/100 g dose of either EF or EC are very close to the 
expected dose for .normalizing propulsion rate (75.4 + 6.0% 
h-1 ). The calculated dose for normalization of propulsion 
should be (75.4 ·- ! (63.5 + 66.0) ml/100 g) roughly 0.86 ml/ 
' . 
100 g of either extract. This calculated dose should 
prevent the induced diarrhoea in the rats. 
A few minutes ( <. 10 min) after gavaging the animals in 
groups 3a ·-and~d--with the aqueous extracts (relativeLy high 
doses), the animals became cataleptic and locomotion was 
reduced sig~ificantly. 
On examining the excised small intestine, a dose of~ 1 mg/ 
100 g morphine, as well as the highest dose of extract used 
(Ec), caused a strong spasm in the whole intestine with 
·almost occlusion of the lumen of the tract beyond the front 
of the dye marker. 
Discussion 
Even though Microlax is used clinically as a microehema, in 
the diluted form (1/9, v/v in H20) and at~ dose which is 8x 
the hUman enema dose, it was effective in produ~ing 
experimental di~rrhoea in Sprague-Dawley rats. The mode of 
action of Microlax, according to the manufacturers, 
Pharmacia AB of Sweden, is an osmotic effect that draws 
large amounts of water from the extra7cellular space of 
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intestinal tissues into the lumen, without any stimulant 
action on the intestinal smooth muscle and without any 
systemic effects. Thus, it would appear that this type of 
experimental diarrpoea would be more appropriate for 
investigatory work on antidiarrhoeal activity, since the 
increased secretion and decreased reabsorption of water and 
electrolytes in diarrhoeal states of the intestine are 
. . 
• 
currently the targets of therapeutics, rather than effects 
on motility changes as could be induced by the administration 
of castor oil in experimental animals. It would appear that 
-
-----the effect cf the aqueous extract, at least at doses that 
normalize propulsion, was due to a large extent on the 
inhibition of the action of Microlax on the transport of 
intestinal extracellular fluid. This.may be due either to 
stimulation of the reabsorption process or to an antisecre-
tory activity, the latter being more plausible because of 
the known antimuscarinic effect due to inhibition of acetyl-
choline release in the Auerbach' s· pelxus (.Lutterodt , .. l98R). 
But to this effect must·be added the spasmolytic activity of 
the extract (Lutterodt, 1988). 
Because of the ubiquitous abundance of the guava tree, with 
ne:arly: . every tropical village or hamlet having from a few 
to many trees growing in or around dwelling places, there is 
virtually no limit to the supply of the leaves. Unfortunate-
ly, knowledge of the antidiarrhoeal usefulness of .the leaf 
is surprisingly low. In a survey carried out in villages 
around Kota Bharu, the capital of Kelantan State in Malaysia, 
almost half (46.8% of a random sample of 205) of the 
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population interviewed were ignorant of this use of the leaf 
although in some villages all interviewed had knowledge of 
its antidiarrhoeal efficacy in acute diarrhoeal diseases. A 
few volunteered the information that the guava leaf is their 
trusted remedy for acute diarrhoea for years. (Lutterodt, 
1991, unpublished). The plant is propagated in.the wild 
mainly by animal dispersal of the indigestibl~ stony seeds 
of the·fleshy fruit, but it is also cultivated in house 
gardens and in orchards, especially the exotic and improved 
cultivars, for manufactu~ing .g~~'?'~_jams_:_ ____ .. __ _ 
' 
The World Health Organization, WHO, since 1947, has 
collaborated closely in several multiple projects· of many 
research bodies and government organi~ations, and by the 
1970s there were new possibilities for a better understanding 
of the pathogenesis of the acute diarrhoeas and for the 
development of improved methods of diagnosis, treatment and 
prevention, including oral vaccines, which were later to 
prove ineffective, contributing to the abolition of the 
requirement of cholera vaccination for international travel 
in the International Health Regulations in 1973 by the World 
Health Assembly. Most important was the demonstration by 
WHO field studies of the effectiveness of a single oral 
rehydration salts (ORS) formulation in the treatment of all 
diarrhoeas, including cholera, in all age groups (Martinez, 
c.A. et al., 1988)r.which so convinced public health 
administrators around the world that diarrhoeal diseases 
control should become an essential component of national 
primary health progr~mnes. In 1978, the 31st World Health 
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Assembly launched the global diarrhoeal diseases control 
progrrumme (CDD), and between 1980 and 1987, the total number 
of multidisciplinary research programmes supported by the 
VffiO through the CDD was 452. 
Research in oral rehydration therapy (ORT) has shown that a 
. 
more stable formulation o~ ORS containing trisodium citrate 
dihydrate is effective as ORS containing sodiUm bicarbonate 
and may result in less stool output in high-purging patients. 
It has also been shown that ORS containing cooked rice 
powder ·in place ·o·f-gJ.uc-ose res-ults in a 13-42% reduction in-
daily diarrhoeal output, a 17-30% reduction in the duration 
of diarrhoea and a 15-49% reduction in total stool volume 
(Martinez et al., 1988). 
The efficacy of ORT in acute diarrhoeas is now firmly 
established. Be that ~s it may, the availability of ORT in 
many countries, especially in Third-World poor countries, is 
very disappointingly low, even in some urban and sub-urban 
clinical facilities. By 1989 '· the WHO targeted number of 
countries that should be in production of ORS was 60 (only 
55 in 1987). Poorer countries, for whom, ironically, 
diarrhoeal diseases form the major cause of morbidity and . 
mortality, may not be in a position either to start or main-
tain production, or may have problems with the logistics of 
making ORS available nationwide. 
The guava leaf has been used very successfully for many 
centuries against diarrhoeal diseases. In South-East Asia 
and especially in China, the leaf is first fed to the giant 
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thorny stick insect, Hepteropteryx dilata,or other insects 
such as the walking stick insect or the praying mantis and 
the droppings of the insect in dry pellet forms are collected 
and stored. A feW of these pellets are used when necessary 
by extraction in hot water, giving a pleasantly fl~voured 
wine-coloured drink, which is claimed to be efficacious in 
the treatment of acute diarrhoeas (Lutterodt, 1988). This 
• 
knowledge, like the use of the leaves, is slowly disappearing 
because of over-reliance on treatment in the Western medical 
system with drugs. Many poor villagers simply do not go to 
. . - ·- --- ----
hospitals because they cannot pay for the simplest of treat-
ment, including diarrhoeal cases. 
If knowledge of the use .of this traditional medicine is 
rekindled, many lives could be saved in poor Third-World 
countries, since early treatment, in most cases of diarrhoea, 
prevents the development of the more serious and life-
threatening event of dehydration, especially in babies and 
very young children. 
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TABLE 1 
GROUP OF RATS (200-250 g) AND GAVAGES GIVEN IN THE DETERMINATION OF .· 
INTESTINAL PROPULSION RATE AND ITS INHIBITION BY MORPHINE AND EXTRACTS · 
FROM PSIDIUM GUAJAVA LEAF 













8 Water ( 1. 0 m1j1·00 g) Liquid paraffin (1.0 m1/100 g) 
11 Water (1.0 ml/100 g) Microlax (1. 0 ml/100 g) 
.. 5 Morphine (0.3 ml/100 g) Micro lax (1.0 ml/100 g) 
5 Morphine (1. 0 ml/100 g) Microlax (1. 0 ml/100 g) 
4 Morphine '(2. 0 m1/ 100 g) Microlax (1. 0 ml/100 g) 
5 Extract ED (1.0 ml/100 g)* Microlax (1.0 rr!1/100 g) 
5 Extract EF (1.0 ml/100 g)* Microla.x · (1.0 m1/100 g) 
6 Extract Ec (1.0 ml/100 g)* Micro1ax ( 1. 0 ml/ 100 g) 
5 Extract Ec (2.0 ml/100 g)* Micro1ax (1.0 m1/100 g) 
Animals were gavaged 1 h before challenge with Microlax·or liquid 
paraffin . (Treatment) 
E E are aqueous extracts (by boiling) of the dried (D) and 
D' F fresh (F) leaves. EC is aqueous extract of fresh leaves ground 
· t extracted cold (C) at· laboratory temperature. 
1.nto a pas e 
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TABLE 2 
ANTIDIARRHOEAL ACTION OF EXTRACTS OF PSIDIUM GUAVA LEAF .AND MORPHINE 
IN GROUPS OF RATS+ CHALLENGED WITH MICROLAX* (1.0 ml/100 g) FOR 60 
MINUTES 
Meal distance** Hyper propulsion 
Group N ·% Inhibition % Intestine length 
la 8 Water (1.0 ml/100 g) 75.4 :t 6.0 
lb 18 Water (1.0 ml/100 g) 98.8 :t 1.8 0** 
2a 5 Morphine . (0. 3 mg/100 g) 96.3 :t 1.8 2.5 












5 Morphine (1. 0 mg/100 g) 78.0 :t 7.6 21.1 
4 Morphine {2. 0 mg/100 g) 34.0 :t 8.2 65.6 
5 Extract:·ED (1. 0 ml/100 g) 43.3 :t 5.2 56.2 
~ 
6 Extract EF (1.0 ml/100 g) 63.5 :t 8.8 35.7 
5 Extract_Ec (1.0 ml/100 g) 66.0 :t 15.3 33.2 
5 Extract Ec· (2.0 ml/100 g) 36.3 :t 5.4 63.6 
same groups and rats in Table l 
A microenema (diluted 1:9 in water) as the cathartic agent. 
Group la received liquid.paraffin as control for the determination 
of normal rate of propulsion. 
'Meal distance' is the measured length (from.the pyloric sphincter) · 
of intestine traversed by the meal-dye solution. 
% Values are the me~n :t SD 
The value 98.8% was taken as the reference for hyperpropulsion. 
